Trial · NCT03833895
The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section
NCT03833895, Phase 2, Phase 3, Completed, China International Neuroscience Institution
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section. Trials, record NCT03833895. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03833895
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Phenylephrine vs. Norepinephrine Infusion Undergoing Cesarean Section
- NCT number
- NCT03833895
- Status
- Completed
- Phases
- Phase 2, Phase 3
- Enrollment
- 238 participants, actual
- Lead sponsor
- China International Neuroscience Institution
- Conditions
- Cesarean Section Complications
- Interventions
- Norepinephrine, Phenylephrine, Ringer's Solution
- First posted
- 2019-02-07
- Last updated
- 2020-02-10
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Systolic blood pressure (SBP) change as the one of hemodynamic outcome in general monitoring | through study completion, an average of 24 hour | Systolic blood pressure (SBP) |
| Primary | Diastolic blood pressure (DBP) change as the one of hemodynamic outcome in general monitoring | Through study completion | Diastolic blood pressure (DBP) |
| Primary | Mean arterial pressure (MAP) change as the one of hemodynamic outcome in general monitoring | An average of 24 hour | Mean arterial pressure (MAP) |
| Primary | Heart rate (HR) change as the one of hemodynamic outcome in general monitoring | Through the study completion, an average of 24 hour | Heart rate (HR) |
| Primary | Stroke volume (SV) as the part of LIDICO-rapid monitoring parameter for parturient | Through study completion, an average of 24 hour | Stroke volume (SV) |
| Primary | Cardiac output (CO) as the part of LIDICO-rapid monitoring parameter for parturient | Through study completion, an average of 24 hour | Cardiac output (CO) |
| Primary | Systemic vascular resistance (SVR) as the part of LIDICO-rapid monitoring parameter for parturient | Through study completion, an average of 24 hour | Systemic vascular resistance (SVR) |
| Secondary | The benefits to the fetus based on umbilical vein (UV) blood gas | Through study completion, an average of 24 hour | The umbilical vein (UV) blood gas |
| Secondary | The benefits to the fetus based on umbilical artery (UA) blood gas | Through study completion, an average of 24 hour | The umbilical artery (UA) blood gas |
| Secondary | The benefits to parturient based on peripheral vein (PV) blood gas | Through study completion, an average of 24 hour | Peripheral vein (PV) blood gas |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 32894044 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03833895
GET https://conductscience.org/api/trials/v1/NCT03833895/registered